Emeritus Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.05 M
- Paid Up Capital ₹ 0.14 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 40.43%
- Profit Growth -29933.76%
- Ebitda -1797.51%
- Net Worth 269820.36%
- Total Assets 3390.37%
About Emeritus Pharma
Emeritus Pharma Private Limited (EPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 December 2017 (Seven years and one month 14 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.05 M and a paid-up capital of Rs 0.14 M, as per Ministry of Corporate Affairs (MCA) records.
Jyoti Narang, Ankur Agarwal, and Parasharan Chari serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909GJ2017PTC100254
-
Company No.
100254
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Dec 2017
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Emeritus Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Narang
|
Nominee Director | 19-May-2022 | Current |
|
Ankur Agarwal
|
Director | 21-Sep-2019 | Current |
|
Parasharan Chari
|
Director | 29-May-2021 | Current |
Financial Performance of Emeritus Pharma.
Emeritus Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.43% increase. The company also saw a substantial fall in profitability, with a 29933.76% decrease in profit. The company's net worth Soared by an impressive increase of 269820.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emeritus Pharma?
Unlock access to Emeritus Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Himalia Prime Assets Private LimitedJyoti Narang is a mutual person
-
Brigade Hotel Ventures LimitedJyoti Narang is a mutual person
-
Avanamd Healthcare Private LimitedJyoti Narang is a mutual person
-
Ebsc Technologies Private LimitedJyoti Narang is a mutual person
-
Edubridge Learning Private LimitedJyoti Narang is a mutual person
-
Disha Medical Services Private LimitedJyoti Narang is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Emeritus Pharma?
Emeritus Pharma has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emeritus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emeritus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
